Alaa Hussein Al-Darraji (Patent): IPO 19 Dec 2012

Sufficiency, Support – The invention appears to relate to the use of certain compounds in nuclear imaging for discovering the cause of cancer. The Hearing Officer decided that the claimed invention was not disclosed in a manner that was clear and complete enough for it to be performed by a skilled person, and was not fully supported by the description. She refused the application.

Judges:

Mrs S E Chalmers

Citations:

[2012] UKIntelP o50712, O/507/12

Links:

Bailii

Statutes:

Patents Act 1977 14(3) 14(5)

Intellectual Property

Updated: 10 November 2022; Ref: scu.467725